CDSCO Guidelines on BA/BE Studies: Regulatory Framework for India
CDSCO Guidelines on BA/BE Studies: Regulatory Framework for India Regulatory Overview of BA/BE Studies under CDSCO Guidelines in India Bioavailability (BA) and Bioequivalence (BE) studies play a critical role in establishing therapeutic equivalence between a generic drug and its innovator counterpart. In India, the Central Drugs Standard Control Organization (CDSCO) regulates the conduct of these…
Read More “CDSCO Guidelines on BA/BE Studies: Regulatory Framework for India” »